ArticleScientific reports2023

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.

Cheng-Hsin Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.